XML 17 R4.htm IDEA: XBRL DOCUMENT v3.5.0.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2016
Dec. 31, 2015
Current Assets    
Cash and cash equivalents (variable interest entities restricted - 2016: $135; 2015: $158) $ 7,032 $ 8,577
Accounts and notes receivable:    
Trade (net of allowance for doubtful receivables - 2016: $114; 2015: $94) 4,746 4,078
Other 4,362 3,768
Inventories 8,013 6,871
Other current assets 625 647
Total current assets 24,778 23,941
Investments    
Investment in nonconsolidated affiliates 3,566 3,958
Other investments (investments carried at fair value - 2016: $2,011; 2015: $1,866) 2,995 2,923
Noncurrent receivables 991 765
Total investments 7,552 7,646
Property    
Property 57,499 50,802
Less accumulated depreciation 34,188 32,948
Net property (variable interest entities restricted - 2016: $1,026; 2015: $1,717) 23,311 17,854
Other Assets    
Goodwill 15,491 12,154
Other intangible assets (net of accumulated amortization - 2016: $4,195; 2015: $3,770) 6,326 3,617
Deferred income tax assets 2,483 2,140
Asbestos-related insurance receivables - noncurrent 36 51
Deferred charges and other assets 647 535
Total other assets 24,983 18,497
Total Assets 80,624 67,938
Current Liabilities    
Notes payable 236 454
Long-term debt due within one year 633 541
Accounts payable:    
Trade 4,674 3,577
Other 2,503 2,287
Income taxes payable 480 452
Dividends payable 595 592
Accrued and other current liabilities 3,534 3,212
Total current liabilities 12,655 11,115
Long-Term Debt (variable interest entities nonrecourse - 2016: $395; 2015: $487) 20,423 16,215
Other Noncurrent Liabilities    
Deferred income tax liabilities 1,027 587
Pension and other postretirement benefits - noncurrent 9,839 9,119
Asbestos-related liabilities - noncurrent 348 387
Other noncurrent obligations 5,983 4,332
Total other noncurrent liabilities 17,197 14,425
Stockholders’ Equity    
Preferred stock, series A 4,000 4,000
Common stock 3,107 3,107
Additional paid-in capital 4,916 4,936
Retained earnings 30,884 28,425
Accumulated other comprehensive loss (7,681) (8,667)
Unearned ESOP shares (226) (272)
Treasury stock at cost (5,965) (6,155)
The Dow Chemical Company’s stockholders’ equity 29,035 25,374
Non-redeemable noncontrolling interests 1,314 809
Total equity 30,349 26,183
Total Liabilities and Equity $ 80,624 $ 67,938